Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Non-Interventional Post-Marketing Safety Study on the Long-Term Safety of HYQVIA (Global)

NCT02593188 is registered in ClinicalTrials.gov with Baxalta now part of Shire as lead sponsor.

NCT NCT02593188
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02593188 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Non-Interventional Post-Marketing Safety Study on the Long-Term Safety of HYQVIA (Global)
Lead sponsor
Baxalta now part of Shire
Phase
Observational
Overall status
Completed
Start date
November 12, 2015
Completion date
October 21, 2021
Enrollment
264 (actual)
Sites
30

Conditions

As the registry lists them; a condition with its own page is linked.

primary immunodeficiency diseases (pid)